KG

Kundan Gope

Active Director Director DIN 09081709
DIN 09081709 First appointment Feb 2021 Primary industry Real Estate and Construction
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kundan Gope

Data last updated:

Kundan Gope is a Director at Surakshaa Diagnostic & Hospital Private Limited (since 2021). The company operates in Real Estate and Construction.

DIN 09081709
Primary Designation Director
Industry Real Estate and Construction
First Appointment 02 Feb 2021
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Feb 20212016Active

Directorship timeline

Open interactive timeline →
Surakshaa Diagnostic & Hospital Private Limited
Premium access

Shareholding and investment profile for Kundan Gope

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kundan Gope

Kundan Gope currently holds 1 directorship: Surakshaa Diagnostic & Hospital Private Limited (Director, since 02 Feb 2021).

Kundan Gope was first appointed on 02 Feb 2021 as Director at Surakshaa Diagnostic & Hospital Private Limited.

The current boards of Kundan Gope's companies include Kaushal Singh (Surakshaa Diagnostic & Hospital Private Limited), Mahammad Ishtiyaque (Surakshaa Diagnostic & Hospital Private Limited), Pinaki Pal (Surakshaa Diagnostic & Hospital Private Limited), Pritam Sarkar (Surakshaa Diagnostic & Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available